Literature DB >> 23729623

Structure and function of MK5/PRAK: the loner among the mitogen-activated protein kinase-activated protein kinases.

Ugo Moens1, Sergiy Kostenko.   

Abstract

Mitogen-activated protein kinase (MAPK) pathways are important signal transduction pathways that control pivotal cellular processes including proliferation, differentiation, survival, apoptosis, gene regulation, and motility. MAPK pathways consist of a relay of consecutive phosphorylation events exerted by MAPK kinase kinases, MAPK kinases, and MAPKs. Conventional MAPKs are characterized by a conserved Thr-X-Tyr motif in the activation loop of the kinase domain, while atypical MAPKs lack this motif and do not seem to be organized into the classical three-tiered kinase cascade. One functional group of conventional and atypical MAPK substrates consists of protein kinases known as MAPK-activated protein kinases. Eleven mammalian MAPK-activated protein kinases have been identified, and they are divided into five subgroups: the ribosomal-S6-kinases RSK1-4, the MAPK-interacting kinases MNK1 and 2, the mitogen- and stress-activated kinases MSK1 and 2, the MAPK-activated protein kinases MK2 and 3, and the MAPK-activated protein kinase MK5 (also referred to as PRAK). MK5/PRAK is the only MAPK-activated protein kinase that is a substrate for both conventional and atypical MAPK, while all other MAPKAPKs are exclusively phosphorylated by conventional MAPKs. This review focuses on the structure, activation, substrates, functions, and possible implications of MK5/PRAK in malignant and nonmalignant diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23729623     DOI: 10.1515/hsz-2013-0149

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  17 in total

Review 1.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

2.  p38-Regulated/activated protein kinase plays a pivotal role in protecting heart against ischemia-reperfusion injury and preserving cardiac performance.

Authors:  Yu Tina Zhao; Jianfeng Du; Naohiro Yano; Hao Wang; Jianguo Wang; Patrycja M Dubielecka; Ling X Zhang; Gangjian Qin; Shougang Zhuang; Paul Y Liu; Y Eugene Chin; Ting C Zhao
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-10       Impact factor: 4.249

3.  Erythrocyte mitogen-activated protein kinases mediate hemolytic events under osmotic and oxidative stress and in hemolytic diseases.

Authors:  Kelsey Hazegh; Fang Fang; Kathleen Kelly; Derek Sinchar; Ling Wang; Benjamin E Zuchelkowski; Alexander C Ufelle; Orlando Esparza; Pavel Davizon-Castillo; Grier P Page; Tamir Kanias
Journal:  Cell Signal       Date:  2022-08-25       Impact factor: 4.850

Review 4.  Regulation of cancer metabolism by O-GlcNAcylation.

Authors:  Zhonghua Li; Wen Yi
Journal:  Glycoconj J       Date:  2013-12-10       Impact factor: 2.916

5.  Comparative Analysis of Two Gene-Targeting Approaches Challenges the Tumor-Suppressive Role of the Protein Kinase MK5/PRAK.

Authors:  Natalia Ronkina; Claus Johansen; Lisa Bohlmann; Juri Lafera; Manoj B Menon; Christopher Tiedje; Kathrin Laaß; Benjamin E Turk; Lars Iversen; Alexey Kotlyarov; Matthias Gaestel
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

6.  Comparative molecular dynamics simulations of mitogen-activated protein kinase-activated protein kinase 5.

Authors:  Inger Lindin; Yimingjiang Wuxiuer; Aina Westrheim Ravna; Ugo Moens; Ingebrigt Sylte
Journal:  Int J Mol Sci       Date:  2014-03-19       Impact factor: 5.923

7.  Imatinib treatment causes substantial transcriptional changes in adult Schistosoma mansoni in vitro exhibiting pleiotropic effects.

Authors:  Christin Buro; Svenja Beckmann; Katia C Oliveira; Colette Dissous; Katia Cailliau; Richard J Marhöfer; Paul M Selzer; Sergio Verjovski-Almeida; Christoph G Grevelding
Journal:  PLoS Negl Trop Dis       Date:  2014-06-12

8.  Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.

Authors:  Charny Park; Sang Yun Ha; Seung Tae Kim; Hee Cheol Kim; Jin Seok Heo; Young Suk Park; Gregory Lauwers; Jeeyun Lee; Kyoung-Mee Kim
Journal:  Oncotarget       Date:  2016-01-26

9.  TLK1-mediated MK5-S354 phosphorylation drives prostate cancer cell motility and may signify distinct pathologies.

Authors:  Md Imtiaz Khalil; Vibha Singh; Judy King; Arrigo De Benedetti
Journal:  Mol Oncol       Date:  2022-02-03       Impact factor: 7.449

10.  Accelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2.

Authors:  Elisabeth Lang; Rosi Bissinger; Abul Fajol; Madhuri S Salker; Yogesh Singh; Christine Zelenak; Mehrdad Ghashghaeinia; Shuchen Gu; Kashif Jilani; Adrian Lupescu; Kathleen M S E Reyskens; Teresa F Ackermann; Michael Föller; Erwin Schleicher; William P Sheffield; J Simon C Arthur; Florian Lang; Syed M Qadri
Journal:  Sci Rep       Date:  2015-11-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.